Damora Therapeutics, Inc. (DMRA)
NASDAQ: DMRA · Real-Time Price · USD
22.42
-0.54 (-2.33%)
Jun 3, 2026, 11:20 AM EDT - Market open
Damora Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wedbush | Wedbush | Buy Initiates $35 | Buy | Initiates | $35 | +56.15% | May 28, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Maintains $45 | Buy | Maintains | $45 | +100.76% | May 17, 2026 |
| Leerink Partners | Leerink Partners | Buy Maintains $55 → $51 | Buy | Maintains | $55 → $51 | +127.53% | May 15, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $40 | Buy | Maintains | $40 | +78.45% | May 13, 2026 |
| Guggenheim | Guggenheim | Buy Reiterates $40 | Buy | Reiterates | $40 | +78.45% | Apr 29, 2026 |
| Evercore ISI | Evercore ISI | Buy Initiates $46 | Buy | Initiates | $46 | +105.22% | Mar 25, 2026 |
| UBS | UBS | Buy Initiates $45 | Buy | Initiates | $45 | +100.76% | Feb 17, 2026 |